-
The U.S. Food and Drug Administration (FDA) recently issued an alert on the potential risk of non-convulsive status epilepticus associated with the use of cefepime, a broad spectrum fourth generation cephalosporin.
-
FoodNet is an active surveillance program that collects data on 9 laboratory-confirmed pathogens from 10 sites in the United States: 7 states (Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, and Tennessee) and certain counties in California, Colorado, and New York.
-
In this issue: Lorcaserin for weight loss; statins and fatigue; treatment-resistant gonorrhea; hydrocodone classification changes; USPSTF recommendations; and FDA actions.
-
A total of 1745 infants from 17 sites in Brazil (70.1%), South Africa (27.4%), Argentina (1.6%) and the United States (0.8%) born to women with a peripartum diagnosis of HIV type I infection were randomized within 48 hours of birth to receive one of three six-week postpartum antiretroviral regimens.
-
This ProMED-mail alert describes the case of a young Rhode Island resident who traveled to Cambodia and Viet Nam, where she was hospitalized with spinal cord compression in December 2011.
-
Case Summary: A 27- year-old physical education teacher presented with two separate episodes of ill-defined dizziness and mild confusion over a period of one week.
-
In May 2011, an 8-year-old girl developed sore throat, vomiting, and swallowing difficulties. During two emergency room visits with diffuse abdominal pain, she was given intravenous fluids and diagnosed with a viral illness.
-
A retrospective review of pediatric cases of dengue fever was undertaken at a single health center in the Bronx area of New York. Over a 3 ½ year period, eight children with dengue infection were identified.
-
In this issue: Statins and diabetes risk; new treatment guideline for diabetes; new pertussis vaccine recommendation; antibiotics and rhinosinusitis; fluoroquinolones and cystitis; and FDA actions.
-
Currently, intravenous artesunate for the treatment of severe falciparum malaria is dosed at 0, 12, 24, 48, and 72 hours with a total dose of 12 mg/kg (5-dose regimen).
